In a recent preclinical study, Seragon Biosciences’ SRN-901 extended the remaining lifespan of middle-aged mice by approximately 34%. Led by Senior Scientist David Brown, the study demonstrated improved physical endurance and gene expression resembling youthful profiles. These findings offer promising evidence for potential anti-aging therapies and innovative prospects in biomedical longevity research.